Date of Award

8-2010

Degree Type

Thesis

Degree Name

MS Biology

Department

Biology

Advisor

Anne M. Pumfery

Committee Member

Allan Blake

Committee Member

Heping Zhou

Committee Member

Carroll Rawn

Keywords

Kaposi's sarcoma, Herpesvirus, Bcl-2 protein, Apoptosis

Abstract

Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of various diseases, and it encodes a Bcl-2 homolog, KS-Bcl-2. The Bcl-2 family is important in regulating cellular apoptosis. Pro-apoptotic Bcl-2 family members promote apoptosis through mitochondrial pore formation by Bak and Bax, or through BH3 only domain activators and sensitizers. Anti-apoptotic members, such as cellular Bcl-2 prevent apoptosis through interactions with pro-apoptotic proteins, for instance inhibiting pore formation by binding to Bak and/or Bax. Even though, KS-Bcl-2 has been shown to have an anti-apoptotic function like its homolog, it does not bind to either Bak or Bax, and little is known about the mechanism behind KS-Bcl-2's function. A second mitochondrial apoptotic pore is the mPTP, which is made up of ANT and VDAC. Bcl-2 and Bcl-xL have been shown to prevent apoptosis through interactions with these proteins. In order to further investigate the mechanism behind KS-Bcl-2's anti-apoptotic function the localization and binding to the mPTP needed to be determined. KS-Bcl-2 was transfected into Vero cells and then localization was observed under normal and apoptotic conditions. Under normal conditions KS-Bcl-2 localized to the mitochondria, cytoplasm, and nucleus and during apoptosis primarily the mitochondria. Furthermore, to evaluate KS-Bcl-2's interaction with mPTP proteins a OST-pull down assay was performed using isolated GST-KS-Bcl-2 and mitochondrial proteins, and then evaluated for VDAC. It was observed that VDAC and KS-Bcl-2 do interact, and that this interaction could potentially be the mechanism behind KS-Bcl-2's anti-apoptotic function. Further studies are needed to determine the functionality of this interaction.

Share

COinS